Search research articles
Contact Us
Filters
Showing results (201-210 of 350) with videos related to
Page
of 35
Sort By:
Macromolecular Bioscience
|
January 17, 2016
Gelatin Nanoparticles with Enhanced Affinity for Calcium Phosphate
Kambiz Farbod, Mani Diba, Tatiana Zinkevich, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 24, 2018
Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population
Valvanera Vozmediano, John C Lukas, Esther Encinas, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 28, 2024
Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection
Clémence Boivin-Champeaux, Nieves Velez de Mendizabal, Aksana Jones, et al.
Multiple Sclerosis and Related Disorders
|
July 14, 2021
Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practice
Martin Stangel, Veit Becker, Birte Elias-Hamp, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 3, 2024
Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation
Marian Klose, Rodrigo Cristofoletti, Carolina de Miranda Silva, et al.
Pharmacotherapy
|
September 29, 2023
Modifiable statin characteristics associated with potential statin-related prescribing cascades
Grace Hsin-Min Wang, Earl Morris, Scott M Vouri, et al.
Journal of Clinical Pharmacology
|
September 8, 2020
Development and Verification of a Body Weight-Directed Disease Trial Model for Glucose Homeostasis
Nashid Farhan, Ines Gebert, Yifan Xing, et al.
Therapeutic Advances in Neurological Disorders
|
April 15, 2024
Real-world evidence and patient preference for subcutaneous <i>versus</i> intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis - initial results from the observational SISTER study
Ralf Gold, Stephan Schmidt, Florian Deisenhammer, et al.
The AAPS Journal
|
April 4, 2024
Mechanistic Modeling of In Vitro Biopharmaceutic Data for a Weak Acid Drug: A Pathway Towards Deriving Fundamental Parameters for Physiologically Based Biopharmaceutic Modeling
Venkata Krishna Kowthavarapu, Nitin Bharat Charbe, Churni Gupta, et al.
Journal of Neurology
|
May 1, 2008
Does high field MRI allow an earlier diagnosis of multiple sclerosis?
Mike P Wattjes, Michael Harzheim, Götz G Lutterbey, et al.
Page
of 35
Search research articles
Search
Showing results (201-210 of 350) with videos related to
Sort By:
Page
of 35
Macromolecular Bioscience
|
January 17, 2016
Gelatin Nanoparticles with Enhanced Affinity for Calcium Phosphate
Kambiz Farbod, Mani Diba, Tatiana Zinkevich, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 24, 2018
Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population
Valvanera Vozmediano, John C Lukas, Esther Encinas, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 28, 2024
Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection
Clémence Boivin-Champeaux, Nieves Velez de Mendizabal, Aksana Jones, et al.
Multiple Sclerosis and Related Disorders
|
July 14, 2021
Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practice
Martin Stangel, Veit Becker, Birte Elias-Hamp, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 3, 2024
Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation
Marian Klose, Rodrigo Cristofoletti, Carolina de Miranda Silva, et al.
Pharmacotherapy
|
September 29, 2023
Modifiable statin characteristics associated with potential statin-related prescribing cascades
Grace Hsin-Min Wang, Earl Morris, Scott M Vouri, et al.
Journal of Clinical Pharmacology
|
September 8, 2020
Development and Verification of a Body Weight-Directed Disease Trial Model for Glucose Homeostasis
Nashid Farhan, Ines Gebert, Yifan Xing, et al.
Therapeutic Advances in Neurological Disorders
|
April 15, 2024
Real-world evidence and patient preference for subcutaneous <i>versus</i> intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis - initial results from the observational SISTER study
Ralf Gold, Stephan Schmidt, Florian Deisenhammer, et al.
The AAPS Journal
|
April 4, 2024
Mechanistic Modeling of In Vitro Biopharmaceutic Data for a Weak Acid Drug: A Pathway Towards Deriving Fundamental Parameters for Physiologically Based Biopharmaceutic Modeling
Venkata Krishna Kowthavarapu, Nitin Bharat Charbe, Churni Gupta, et al.
Journal of Neurology
|
May 1, 2008
Does high field MRI allow an earlier diagnosis of multiple sclerosis?
Mike P Wattjes, Michael Harzheim, Götz G Lutterbey, et al.
Page
of 35